Jabar A. Faraj

646 total citations
25 papers, 551 citations indexed

About

Jabar A. Faraj is a scholar working on Pharmaceutical Science, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Jabar A. Faraj has authored 25 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmaceutical Science, 6 papers in Molecular Biology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Jabar A. Faraj's work include Advanced Drug Delivery Systems (10 papers), Drug Solubulity and Delivery Systems (7 papers) and Neuropeptides and Animal Physiology (5 papers). Jabar A. Faraj is often cited by papers focused on Advanced Drug Delivery Systems (10 papers), Drug Solubulity and Delivery Systems (7 papers) and Neuropeptides and Animal Physiology (5 papers). Jabar A. Faraj collaborates with scholars based in United States, Italy and Iraq. Jabar A. Faraj's co-authors include Patrick P. DeLuca, Susan D’Souza, Stefano Giovagnoli, Yılmaz Çapan, Kai P. Leung, Dong Hee Na, Rossella Dorati, Anwar Hussain, Yukihiko Aramaki and Ken Iseki and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Controlled Release and Pharmaceutical Research.

In The Last Decade

Jabar A. Faraj

24 papers receiving 527 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jabar A. Faraj United States 13 291 126 107 86 76 25 551
Gayasuddin Khan India 16 267 0.9× 89 0.7× 335 3.1× 20 0.2× 145 1.9× 20 745
Giulia Di Prima Italy 14 214 0.7× 110 0.9× 87 0.8× 20 0.2× 37 0.5× 29 478
Fatma Ahmed Ismail Egypt 11 669 2.3× 122 1.0× 89 0.8× 11 0.1× 78 1.0× 21 848
Monika Bansal India 11 164 0.6× 69 0.5× 117 1.1× 25 0.3× 164 2.2× 18 490
Yves Jacques Switzerland 8 454 1.6× 102 0.8× 47 0.4× 17 0.2× 28 0.4× 10 597
Garima Garg India 15 400 1.4× 92 0.7× 85 0.8× 8 0.1× 73 1.0× 29 790
Yajaman Sudhakar India 3 448 1.5× 87 0.7× 73 0.7× 8 0.1× 36 0.5× 5 569
Maha M. A. Nasra Egypt 13 251 0.9× 115 0.9× 68 0.6× 11 0.1× 76 1.0× 18 526
Mahmoud M. Ghorab Egypt 19 681 2.3× 149 1.2× 145 1.4× 17 0.2× 9 0.1× 34 994
V. Ravi Sankar India 8 248 0.9× 72 0.6× 70 0.7× 8 0.1× 74 1.0× 18 504

Countries citing papers authored by Jabar A. Faraj

Since Specialization
Citations

This map shows the geographic impact of Jabar A. Faraj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jabar A. Faraj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jabar A. Faraj more than expected).

Fields of papers citing papers by Jabar A. Faraj

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jabar A. Faraj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jabar A. Faraj. The network helps show where Jabar A. Faraj may publish in the future.

Co-authorship network of co-authors of Jabar A. Faraj

This figure shows the co-authorship network connecting the top 25 collaborators of Jabar A. Faraj. A scholar is included among the top collaborators of Jabar A. Faraj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jabar A. Faraj. Jabar A. Faraj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Faraj, Jabar A., et al.. (2023). Evaluation of Two Assays Immunochromatography and RT-PCR for detection of Rotavirus in Iraqi Children. Research Journal of Pharmacy and Technology. 1355–1358.
2.
Faraj, Jabar A., et al.. (2022). Reprogramming the tumor microenvironment to improve the efficacy of cancer immunotherapies. Medical Oncology. 39(12). 239–239. 11 indexed citations
3.
Faraj, Jabar A., et al.. (2021). Evaluation of the Wheat Germ Oil Topical Formulations for Wound Healing Activity in Rats. Pakistan Journal of Biological Sciences. 24(6). 706–715. 2 indexed citations
4.
Faraj, Jabar A., et al.. (2020). Development of an Extended-Release Exenatide Once a Week Depot Formulation. Systematic Reviews in Pharmacy. 11(11). 1947–1952. 1 indexed citations
5.
Faraj, Jabar A., et al.. (2020). Preparation, In Vitro and In Vivo Studies of Vitamin B12 Loaded Implants. Systematic Reviews in Pharmacy. 11(7). 1–5. 1 indexed citations
6.
Al-Ghananeem, Abeer M., Kai P. Leung, Jabar A. Faraj, & Patrick P. DeLuca. (2017). Development of a Sustained Antiplaque and Antimicrobial Chewing Gum of a Decapeptide. AAPS PharmSciTech. 18(6). 2240–2247. 11 indexed citations
7.
D’Souza, Susan, Jabar A. Faraj, Rossella Dorati, & Patrick P. DeLuca. (2015). Enhanced Degradation of Lactide-co-Glycolide Polymer with Basic Nucleophilic Drugs. INFM-OAR (INFN Catania). 2015. 1–10. 22 indexed citations
8.
D’Souza, Susan, Jabar A. Faraj, Stefano Giovagnoli, & Patrick P. DeLuca. (2014). Development of Risperidone PLGA Microspheres. Journal of Drug Delivery. 2014. 1–11. 39 indexed citations
9.
D’Souza, Susan, Jabar A. Faraj, Stefano Giovagnoli, & Patrick P. DeLuca. (2014). In vitro–in vivo correlation from lactide-co-glycolide polymeric dosage forms. Progress in Biomaterials. 3(2-4). 131–142. 35 indexed citations
10.
D’Souza, Susan, Jabar A. Faraj, Rossella Dorati, & Patrick P. DeLuca. (2014). A Short Term Quality Control Tool for Biodegradable Microspheres. AAPS PharmSciTech. 15(3). 530–541. 22 indexed citations
11.
D’Souza, Susan, Jabar A. Faraj, & Patrick P. DeLuca. (2013). Microsphere delivery of Risperidone as an alternative to combination therapy. European Journal of Pharmaceutics and Biopharmaceutics. 85(3). 631–639. 23 indexed citations
12.
Leung, Kai P., et al.. (2009). Antimicrobial Peptides for Plaque Control. Advances in Dental Research. 21(1). 57–62. 24 indexed citations
13.
Na, Dong Hee, Jabar A. Faraj, Yılmaz Çapan, Kai P. Leung, & Patrick P. DeLuca. (2007). Stability of Antimicrobial Decapeptide (KSL) and Its Analogues for Delivery in the Oral Cavity. Pharmaceutical Research. 24(8). 1544–1550. 46 indexed citations
14.
Faraj, Jabar A., Rossella Dorati, Aurélie Schoubben, et al.. (2007). Development of a peptide-containing chewing gum as a sustained release antiplaque antimicrobial delivery system. AAPS PharmSciTech. 8(1). E177–E185. 46 indexed citations
15.
D’Souza, Susan, Jabar A. Faraj, & Patrick P. DeLuca. (2005). A model-dependent approach to correlate accelerated with real-time release from biodegradable microspheres. AAPS PharmSciTech. 6(4). E553–E564. 74 indexed citations
16.
Na, Dong Hee, et al.. (2005). Chewing gum of antimicrobial decapeptide (KSL) as a sustained antiplaque agent: Preformulation study. Journal of Controlled Release. 107(1). 122–130. 45 indexed citations
17.
D’Souza, Susan, et al.. (2003). Development and evaluation of long-acting microsphere dosage forms of risperidone. 1 indexed citations
18.
Faraj, Jabar A., Anwar Hussain, Yukihiko Aramaki, et al.. (1990). Mechanism of Nasal Absorption of Drugs. IV: Plasma Levels of Radioactivity following Intranasal Administration of [3H]Leucine Enkephalin. Journal of Pharmaceutical Sciences. 79(9). 768–770. 10 indexed citations
19.
Faraj, Jabar A., Anwar Hussain, Yukihiko Aramaki, et al.. (1990). Mechanism of Nasal Absorption of Drugs. III: Nasal Absorption of Leucine Enkephalin. Journal of Pharmaceutical Sciences. 79(8). 698–702. 29 indexed citations
20.
Hussain, Anwar, et al.. (1985). Hydrolysis of leucine enkephalin in the nasal cavity of the rat — A possible factor in the low bioavailability of nasally administered peptides. Biochemical and Biophysical Research Communications. 133(3). 923–928. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gayasuddin Khan Breakdown of academic impact, for papers by Giulia Di Prima Breakdown of academic impact, for papers by Fatma Ahmed Ismail Breakdown of academic impact, for papers by Monika Bansal Breakdown of academic impact, for papers by Yves Jacques Breakdown of academic impact, for papers by Garima Garg Breakdown of academic impact, for papers by Yajaman Sudhakar Breakdown of academic impact, for papers by Maha M. A. Nasra Breakdown of academic impact, for papers by Mahmoud M. Ghorab Breakdown of academic impact, for papers by V. Ravi Sankar
Rankless by CCL
2026